We are live on ! Find out more
MC

Muhlenkamp & Co Portfolio holdings

AUM $380M
1-Year Est. Return 43.74%
This Fund
S&P 500
This Quarter Est. Return
+4.11%
1 Year Est. Return
+43.74%
3 Year Est. Return
+121.38%
5 Year Est. Return
10 Year Est. Return
AUM
$317M
AUM Growth
+$52M
Cap. Flow
+$44.8M
Cap. Flow %
14.15%
Top 10 Hldgs %
45.66%
Holding
80
New
24
Increased
14
Reduced
28
Closed
2

Sector Composition

1 Healthcare 26.45%
2 Technology 16.37%
3 Consumer Discretionary 13.25%
4 Financials 11.45%
5 Industrials 10.12%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BFH icon
1
Bread Financial
BFH
$3.97B
$27.2M 8.6%
149,363
-1,285
-0.9% -$224K
AAPL icon
2
Apple
AAPL
$4.89T
$17.3M 5.45%
596,048
-4,396
-0.7% -$125K
ON icon
3
ON Semiconductor
ON
$34.3B
$15.9M 5.02%
1,246,005
-9,260
-0.7% -$111K
GILD icon
4
Gilead Sciences
GILD
$169B
$15.3M 4.81%
212,995
-1,500
-0.7% -$111K
MSFT icon
5
Microsoft
MSFT
$2.98T
$14.5M 4.57%
233,013
-1,725
-0.7% -$104K
RUSHA icon
6
Rush Enterprises Class A
RUSHA
$6.19B
$12.3M 3.88%
866,255
LCI
7
DELISTED
Lannett Company, Inc.
LCI
$11.1M 3.51%
126,095
+58,362
+86% +$5.39M
SAVE
8
DELISTED
Spirit Airlines, Inc.
SAVE
$10.6M 3.33%
182,585
-8,695
-5% -$448K
BMY icon
9
Bristol-Myers Squibb
BMY
$124B
$10.5M 3.3%
178,961
-1,355
-0.8% -$74.1K
MCK icon
10
McKesson
MCK
$98.5B
$10.1M 3.18%
71,767
+26,014
+57% +$3.83M
HBI
11
DELISTED
Hanesbrands
HBI
$10M 3.17%
465,876
+69,171
+17% +$1.65M
CE icon
12
Celanese
CE
$5.02B
$9.65M 3.05%
122,620
-1,100
-0.9% -$82.7K
WCIC
13
DELISTED
WCI Communities, Inc.
WCIC
$9.54M 3.01%
406,805
-3,690
-0.9% -$86.2K
UNH icon
14
UnitedHealth
UNH
$384B
$9.46M 2.99%
59,095
-565
-0.9% -$84.4K
GLD icon
15
SPDR Gold Trust
GLD
$130B
$9.37M 2.96%
85,445
-1,270
-1% -$147K
TEVA icon
16
Teva Pharmaceuticals
TEVA
$37.5B
$8.7M 2.75%
239,889
+64,119
+36% +$2.56M
FHI icon
17
Federated Hermes
FHI
$4.53B
$8.48M 2.68%
+299,866
New +$8.31M
CELG
18
DELISTED
Celgene Corp
CELG
$8.41M 2.66%
72,688
-827
-1% -$92.1K
GME icon
19
GameStop
GME
$9.84B
$6.65M 2.1%
+1,052,496
New +$6.5M
BIIB icon
20
Biogen
BIIB
$30.8B
$6.6M 2.08%
23,279
-199
-0.8% -$59K
DAL icon
21
Delta Air Lines
DAL
$57B
$6.54M 2.06%
132,970
-1,035
-0.8% -$47.2K
GMLP
22
DELISTED
Golar LNG Partners LP
GMLP
$6.29M 1.99%
261,710
-2,585
-1% -$55K
SLB icon
23
SLB Ltd
SLB
$70.4B
$6.19M 1.95%
73,771
+13,786
+23% +$1.13M
CCJ icon
24
Cameco
CCJ
$38B
$5.77M 1.82%
+551,392
New +$4.98M
ALGT icon
25
Allegiant Air
ALGT
$2.83B
$5.72M 1.81%
34,390
+132
+0.4% +$20.6K

Similar funds

Muhlenkamp & Co's Q4 2016 Portfolio in Review

As of Q4 2016, Muhlenkamp & Co held 80 positions worth $317M, up 20% from $265M the previous quarter. Its ten largest holdings account for 46% of the portfolio.

Muhlenkamp & Co deployed $44.8M of net new capital in Q4 2016, opening 24 new positions and adding to 14 existing holdings. Its largest new stake was Federated Hermes: 299,866 shares worth $8.48M.

By sector, the portfolio is most concentrated in Healthcare at 26% of assets, down from 30% a quarter earlier, followed by Technology and Consumer Discretionary.

On the sell side, the largest reduction was Quorum Health Corporation, an estimated $450K trimmed.

  • Muhlenkamp & Co's largest Q4 2016 buy was Federated Hermes: 299,866 shares worth $8.48M.
  • Muhlenkamp & Co added most to Lannett Company, Inc. in Q4 2016, an estimated $5.39M increase.
  • Muhlenkamp & Co's biggest Q4 2016 reduction was Quorum Health Corporation, cutting an estimated $450K.
  • Muhlenkamp & Co fully exited DoubleLine Income Solutions Fund in Q4 2016, selling an estimated $646K.
  • Muhlenkamp & Co's ten largest holdings make up 46% of its $317M portfolio in Q4 2016.
  • Muhlenkamp & Co opened 24 new positions and closed 2 in Q4 2016.
  • Muhlenkamp & Co's portfolio value rose 20% quarter-over-quarter to $317M.

Based on Muhlenkamp & Co's 13F filing for Q4 2016, filed 9 Feb 2017.